35 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
Mid-Morning Market Update: Markets Rise; Bank of America Posts Upbeat Profit
Following the market opening Wednesday, the Dow traded up 0.12% to 35,411.14 while the NASDAQ rose 0.90% to 14,638.13. The S&P also rose, gaining, 0.44% to 4,597.47.
Why Zogenix Shares Are Soaring Today
Zogenix Inc (NASDAQ: ZGNX) is trading significantly higher Wednesday morning after the company announced it received a proposal to be acquired by UCB for approximately $1.9 billion.
UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights
Belgian-based UCB SA (OTC: UCBJF) has agreed to buy Zogenix Inc (NASDAQ: ZGNX), a U.S.
UCB Announced it Will Acquire Zogenix for $26/Share in Cash
UCB (Euronext: UCB) and Zogenix (NASDAQ: ZGNX) announced today that the companies have entered into a definitive agreement under which UCB would acquire Zogenix, Inc., a global biopharmaceutical company commercializing and developing therapies for rare diseases.
Zogenix Submits Type II Variation Application To The European Medicines Agency To Expand The Use Of FINTEPLA For The Treatment Of Seizures Associated With Lennox-Gastaut Syndrome
Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that it has submitted its Type II Variation Market Authorization Application to the
SVB Leerink Maintains Outperform on Zogenix, Lowers Price Target to $32
SVB Leerink analyst Marc Goodman maintains Zogenix (NASDAQ:ZGNX) with a Outperform and lowers the price target from $37 to $32.
